AMPLIFY
Feb 20, 2025•17 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We take a deep look at the recently published, and guideline changing, AMPLIFY trial of fixed-duration acalabrutinib in CLL.
Link: DOI: 10.1056/NEJMoa2409804
For the best experience, listen in Metacast app for iOS or Android